5-Aryl-4-(5-substituted-2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone
- 1 February 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (4) , 1089-1092
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Hsp90 Chaperone MachineryJournal of Biological Chemistry, 2008
- Hsp70 and Hsp90—a relay team for protein folding2004
- 17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma modelsAnti-Cancer Drugs, 2004
- Clinical Development of 17-Allylamino, 17-DemethoxygeldanamycinCurrent Cancer Drug Targets, 2003
- The Hsp90 chaperone complex as a novel target for cancer therapyAnnals of Oncology, 2003
- Heat shock protein 90 as a molecular target for cancer therapeuticsCancer Cell, 2003
- HSP90 as a new therapeutic target for cancer therapy: the story unfoldsExpert Opinion on Biological Therapy, 2002
- Hsp90: Chaperoning signal transductionJournal of Cellular Physiology, 2001
- DT-Diaphorase Expression and Tumor Cell Sensitivity to 17-Allylamino,17-demethoxygeldanamycin, an Inhibitor of Heat Shock Protein 90JNCI: Journal of the National Cancer Institute, 1999
- Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and GeldanamycinJournal of Medicinal Chemistry, 1999